News

On 28 September 2026, the Comité économique des produits de santé (CEPS) and four organisations

On August 31, 2026 the White House announced Most-Favored-Nation drug-pricing agreements with nine more manufacturers:

There is much more money available for biopharma and life sciences in Europe than there

We are delighted to announce that Javier Arribas has been promoted to Partner at Justin

The European Commission has recently announced that the first Joint Clinical Assessment (JCA) is finalised

“We don’t need to worry about Market Access, once we find a partner, they’ll take